When comparing the serum levels of the miRNAs in samples of proven disease recurrence ( n = 12) before treatment start and samples retrieved during the salvage chemotherapy ( n = 15) from the same patients, a trend of decline in levels of miR-371-3 was observed, though due to the small sample size, this difference did not reach statistical significance.
← all excerpts
MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
1
—
—